AI nabs risky abnormalities in the maternity ward

Machine learning can help post-childbirth mothers guard against problems with subsequent pregnancies, potentially saving their lives and those of their future babies.

The technique works by automatically detecting a microscopic abnormality in the placenta called decidual vasculopathy, or DV, on lab slides. Currently many placentas are discarded before being examined for DV due to overbooked perinatal pathologists.

Researchers developed the AI approach to help solve the shortfall with the main aim of preventing preeclampsia, a dangerous disease that affects 2% to 8% of all pregnancies.

The work was conducted at Carnegie Mellon University and the University of Pittsburgh Medical Center. It’s running in the American Journal of Pathology.

The team had multidisciplinary expertise spanning perinatal pathology, computer science and mechanical engineering.

“Ultimately, the approach will allow many more placentas to be screened in a more standardized manner, providing feedback about which cases would benefit most from more in-depth pathologic inspection,” lead author Daniel Clymer, PhD, and colleagues write.

In a news release sent by journal publisher Elsevier, Clymer adds that pathologists need not prepare for reentering the job market.

“The goal here is that this type of algorithm might be able to help speed up the process by flagging regions of the image where the pathologist should take a closer look,” he says.

The study is posted in full for free.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup